Article
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1…
medRxiv · 2023 · Begg, L. R.; Orriols, A. M.; Zannikou, M.; Yeh, C.; Vadlamani, P.; Kanojia, D.; Bolin, R.; Dunne, S. F.; Balakrishnan, S.; Camarda, R.; Roth, D.; Zielinski-Mozny, N. A.; Yau, C.; Vassilopoulos, A.; Huang, T.-H.; Kim, K.-Y. A.; Horiuchi, D.
Key facts
| Title | S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition |
|---|---|
| First author | Begg, L. R.; Orriols, A. M.; Zannikou, M.; Yeh, C.; Vadlamani, P.; Kanojia, D.; Bolin, R.; Dunne, S. F.; Balakrishnan, S.; Camarda, R.; Roth, D.; Zielinski-Mozny, N. A.; Yau, C.; Vassilopoulos, A.; Huang, T.-H.; Kim, K.-Y. A.; Horiuchi, D. |
| Journal | medRxiv |
| Published | Sep 23, 2023 |
| DOI | 10.1101/2023.09.21.558870 |
| Devices mentioned | K190495, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DDG, KLB and 5 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1